WHO ICTRP trial
A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial…
JPRN-jRCT2031220586 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2031220586 |
|---|---|
| Public title | A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial of HZN-825 in Patients with Idiopathic Pulmonary Fibrosis |
| Scientific title | A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects with Idiopathic Pulmonary Fibrosis |
| Primary sponsor | Sakanishi Ryuichi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | ARGENTINA;Japan;AUSTRALIA;Japan;BELGIUM;Japan;BRAZIL;Japan;CANADA;Japan;COLOMBIA;Japan;FRANCE;Japan;GERMANY;Japan;GREECE;Japan;HUNGARY;Japan;ISRAEL;Japan;ITALY;Japan;KOREA, REPUBLIC… |
| Conditions | Idiopathic pulmonary fibrosis (IPF) |
| Interventions | Administer HZN-825 once daily (QD) or twice daily (BID) |
| Registration date | Jan 22, 2023 |
| Target size | 16 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: